Sedative use in the last week of life and the implications for end-of-life decision making.
about
Palliative pharmacological sedation for terminally ill adultsEvidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic reviewPhysician reports of medication use with explicit intention of hastening the end of life in the absence of explicit patient request in general practice in Belgium.Towards a standardised approach for evaluating guidelines and guidance documents on palliative sedation: study protocol.Killing the symptom without killing the patientWhat to do when a competent ICU patient does not want to live anymore but is dependent on life-sustaining treatment? Experience from The Netherlands.Effects of opioids and sedatives on survival in an Australian inpatient palliative care population.Characteristics of Belgian "life-ending acts without explicit patient request": a large-scale death certificate survey revisitedThe Attitudes of Indian Palliative-care Nurses and Physicians to Pain Control and Palliative Sedation.Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China.End-of-life issues in advanced dementia: Part 2: management of poor nutritional intake, dehydration, and pneumonia.An overview of end-of-life issues in the intensive care unitConsiderations of physicians about the depth of palliative sedation at the end of life.Controversies surrounding continuous deep sedation at the end of life: the parliamentary and societal debates in FranceMedication use during end-of-life care in a palliative care centre.Alternative forms of hydration in patients with cancer in the last days of life: study protocol for a randomised controlled trial.Legalised euthanasia will violate the rights of vulnerable patients.Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life.The ethics of palliative sedation as a therapy of last resort.Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practicePalliative Sedation in Advanced Cancer Patients: Does it Shorten Survival Time? - A Systematic ReviewMedical end-of-life practices among Canadian physicians: a pilot studyPalliative sedation in Dutch general practice from 2005 to 2011: a dynamic cohort study of trends and reasons.European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care.Palliative care, double effect and the law in Australia.Contesting the Equivalency of Continuous Sedation until Death and Physician-assisted Suicide/Euthanasia: A Commentary on LiPuma.To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.The practice of continuous palliative sedation in elderly patients: a nationwide explorative study among Dutch nursing home physicians.Continuous deep sedation until death: palliation or physician-assisted death?Palliative sedation until death: an approach from Kant's ethics of virtue.Palliative care professionals' perceptions of nutrition and hydration at the end of life.The use of palliative sedation: A comparison of attitudes of French-speaking physicians from Quebec and Switzerland.[Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study.A survey of the sedation practice of Portuguese palliative care teams.Éliminer les symptômes sans éliminer le patient.Making sense of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved relatives in three European countries.Surrogate End-of-Life Care Decision Makers' Postbereavement Grief and Guilt Responses.Double meanings will not save the principle of double effect.
P2860
Q24186758-ED2E5487-44A3-4127-8211-4AFF9269AD90Q30537819-CEBEBDDA-63D8-49B2-B7DD-DA829FFB35EFQ33551418-0F3EF38D-25EA-49C1-900F-B21C10F49022Q33904189-FC278B12-B62F-4C63-99A5-B256EFE24CCBQ33989020-CCB38EA6-BCAA-440E-AA87-CDFB0F7CDABBQ34311929-448B41C1-B781-46B0-B3B7-30BC1F382181Q34443651-34E919A0-4998-4AF1-AEE9-2719E1547881Q34639607-4509B83B-0766-4D6E-B1BB-EC8272B3D074Q34994159-9D8343B6-4275-4C3C-9165-C810871D2EDEQ35216505-4068EF60-DDA4-4ACC-8D5C-F31599CEE848Q35412780-DAAF3349-8FC6-494E-BB32-64C9097FED3AQ35646582-AA8C80A9-0E6A-4C9E-8A30-854A89B7600BQ35894580-1A050BA4-B824-4CAA-A72F-3D18EE5D3B4BQ36064288-328BEA7E-CC47-47A1-8B38-C90E62BF1BBEQ36123690-FEBED472-ACA0-4B9A-B99B-6BD6BEAC0E4BQ36165748-F7097C08-A2FE-427A-951A-AA9DE8EC86B6Q36265402-5A372A52-B358-4BC0-95F9-87C872346436Q36329212-2A5FF191-C020-4B39-8D88-7A4F079D77E5Q36702546-54F3DA1F-7958-4276-81E9-E63C80C730ABQ36728558-615A52FD-35FB-4783-B8CC-FD2CE582F538Q36924213-40DD2475-394D-4800-B253-87D8F89AF40AQ37066916-E45A38CA-1D95-4110-A156-D571A0A74ECBQ37196825-03D7027C-67A2-4454-AE38-F2BEF4C6D1F1Q37621817-D9447B25-1685-47A4-9067-31CFEE9449EAQ37894858-9FF46A4C-7360-4C94-B6EB-8969558C6309Q38560749-FFD088C3-5BD8-47FE-8876-6F0AA0DC64C9Q38849707-CDBD6C37-1017-44DB-A487-2FDEAB334459Q39175922-B5D8EFF4-AEFE-4F39-9009-7AC9B4F7A789Q39280860-31E0ADEB-FE15-4DAB-965A-FE5E1F038B63Q39294305-C85D41CD-4823-403F-BF9A-7001217A69C7Q39309199-BA4A8C95-F2EB-4439-8221-819323E8A36EQ39843234-16F16D58-5E1E-43C3-92CD-EFE9B01B81A8Q42660336-6C32D810-E72E-4961-A5A6-4E76B4C4A3BDQ42956998-88528FBE-F5D5-4054-9972-45C5E9D3A7F3Q44910489-66DC0561-0149-4EB0-BB09-5BB52F468B77Q45789513-249A0C95-CF78-4966-98A2-AEF59C35D0F9Q46797726-40F11E5E-91A4-42A8-950F-B5B62DDB7E21Q47624475-7F8686B4-6475-4F03-A44C-8D78901DC03EQ47692951-B35F68FB-D0C3-438A-88F1-07DFA4D6903FQ47778769-B68287D1-1B74-41F0-B74E-ACAE3E34241D
P2860
Sedative use in the last week of life and the implications for end-of-life decision making.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Sedative use in the last week ...... r end-of-life decision making.
@ast
Sedative use in the last week ...... r end-of-life decision making.
@en
Sedative use in the last week ...... r end-of-life decision making.
@nl
type
label
Sedative use in the last week ...... r end-of-life decision making.
@ast
Sedative use in the last week ...... r end-of-life decision making.
@en
Sedative use in the last week ...... r end-of-life decision making.
@nl
prefLabel
Sedative use in the last week ...... r end-of-life decision making.
@ast
Sedative use in the last week ...... r end-of-life decision making.
@en
Sedative use in the last week ...... r end-of-life decision making.
@nl
P1476
Sedative use in the last week ...... r end-of-life decision making.
@en
P2093
Andrew Thorns
Nigel Sykes
P304
P356
10.1001/ARCHINTE.163.3.341
P407
P577
2003-02-01T00:00:00Z